Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
116
NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 24, 2020
Completion: Sep 30, 2026